Trends and disparities in colorectal cancer among adults with diabetes mellitus in the United States: A retrospective analysis, 1999-2023.
Abstract
e15674 Background: Colorectal cancer (CRC), the fourth leading cause of cancer-related deaths, affects approximately 1.5 million U.S. adults and is increasingly linked to diabetes. Diabetic patients face elevated mortality due to delayed detection, higher recurrence risk, reduced five-year survival, and poorer prognosis. This study assesses recent demographic trends in CRC mortality with diabetes as a contributing factor. Methods: We analyzed mortality data from the CDC WONDER Multiple Cause-of-Death dataset, using ICD-10 Codes: C18; C19; C20, and E10-E14. Age-adjusted mortality rates (AAMR) per 1,000,000 individuals and annual percentage changes (APC) were calculated by year, gender, race or ethnicity, and location. Results: Between 1999 and 2023, 79,568 deaths occurred from colorectal cancer in diabetic adults. The AAMR declined from 16.94 in 1999 to 13.01 in 2023 (AAPC: -1.15; 95%CI: -1.44 to -0.87). Males showed a higher AAMR of 17.17 versus 9.73 in females. Non-Hispanic (NH) Black or African American individuals had the highest AAMR (19.77), followed by Hispanic or Latino (14.23), NH White (12.48), and NH Asian or Pacific islander (9.29). AAMRs in non-metropolitan (18.52) areas were higher than in Metropolitan areas (13.49). The Midwest region exhibited the highest AAMR, followed by the South, West, and Northeast regions. State-level differences recorded Oklahoma having the highest AAMR (32.81) and Massachusetts the lowest (5.16). Conclusions: Mortality related to colorectal cancer in diabetic adults has declined significantly over the past two decades, disproportionately affecting non-Hispanic Black individuals, residents of non-metropolitan areas and the Midwest region. This emphasizes the need for targeted interventions and greater clinical sensitivity to demographic disparities. Deaths and age-adjusted mortality rates (AAMRs) per 1,000,000 for colorectal cancer related mortality among diabetic adults in the United States from 1999 to 2023. Variable Deaths (n) AAMR (95% CI) Overall 79,568 13.01 (12.58 to 13.44) SEX Male 43,494 17.17 (16.42 to 17.91) Female 36,074 9.73 (9.23 to 10.23) RACE/ETHNICITY NH Blacks 11,535 19.77(18.10 to 21.45) Hispanics 6,233 14.23(12.80 to 15.65) NH White 59,929 12.48(12.02 to 12.95) NH Asians 2,199 9.29 (7.72 to 10.87)
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (16)
Mahmoud Tablawy
Faculty of Medicine Alazhar University, Cairo, Egypt
Amro Ali
Community Regional Medical Center, Fresno, CA
Alyaa Ahmed Ibrahim
Mohamed Fawzi Hemida
FNU Sahil
LUMHS Jamshoro, Jamshoro, Pakistan
Abdelrhman H. Mohamed
Faculty of Medicine, Luxor University, Luxor, Egypt
Abdelrahman Aly Mohamed
Faculty of Medicine, Helwan University, Cairo, Egypt
Ahmed Sami Fdle
Egyptian Ministry of health, Cairo, Egypt
Shehdev Meghwar
LUMHS Jamshoro, Jamshoro, Pakistan
Fnu Urooba
Madina Memon
Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Ahmed Abdelaziz
Ehsanullah Alokozay
Faculty of Medicine, Kandahar University, Kandahar, Afghanistan
Mina Nageh Hemaya
Tbilisi State University, Tbilisi, Georgia
Mohamed Olama
Benha University Hospital, Banha, Egypt
Fatma A. Rikabe
Radiation Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt